Yumanity Therapeutics wants to develop drugs to treat Alzheimer’s, Parkinson’s and ALS.
A new bio-tech company in Massachusetts is trying to come up with treatments for some of the most devastating diseases.
Boston Business Journal reports that the former CEO of Onyx is taking aim at the "problem of the millennium" with his new biotech, Yumanity Therapeutics.
BBJ editor Don Seiffert has more on the story in the above video.
